Loading: 100%
ACETO CORP logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 286 (as per Q3 2017)no data available
Sector Drug Manufacturers, HealthcareDrug Manufacturers, Healthcareno data available
Ticker ACETno data available
Financial year endsFY ends End of Juneno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 1706121824
datesClosing price (adj.)
13.10.201711.16
11.10.201711.33
04.10.201711.64
27.09.201711.11
20.09.201711.20
13.09.201710.66
06.09.201710.41
30.08.201710.47
23.08.201715.80
16.08.201716.03
09.08.201715.95
02.08.201716.31
26.07.201715.40
19.07.201715.10
12.07.201715.25
05.07.201715.45
27.06.201714.82
20.06.201714.90
13.06.201715.02
06.06.201714.37
30.05.201714.24
23.05.201714.51
16.05.201714.36
09.05.201713.60
02.05.201715.89
25.04.201715.55
18.04.201714.76
11.04.201715.21
04.04.201714.92
28.03.201715.15
21.03.201714.50
14.03.201714.69
07.03.201714.69
28.02.201715.11
21.02.201715.37
14.02.201715.33
07.02.201714.84
31.01.201718.80
24.01.201719.53
17.01.201720.08
10.01.201721.11
03.01.201721.54
27.12.201621.39
19.12.201621.05
12.12.201620.63
05.12.201619.88
28.11.201619.48
21.11.201619.38
14.11.201618.86
07.11.201617.20
31.10.201618.00
24.10.201618.57
17.10.201618.40
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
11.16n/a
Market Capitalisation
in million USD
336n/a
Enterprise Value
in million USD
642n/a
Common Shares Outstanding
as per Mar 31, 2017
30,105,000n/a
Preferred Shares Outstanding
as per Mar 31, 2017
n/a
Average Basic Shares Outstanding
TTM
30,885,750n/a
Average Diluted Shares Outstanding
TTM
31,272,250n/a
Index Membership
n/a
Business Summary
Aceto Corp is engaged in the marketing, sells and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, and specialty performance chemicals.
no data available
Key Financials & Ratios (all figures TTM as per Mar 31, 2017, million USD, full statements further below)
Profit & Loss
Revenues 579n/a
Gross Profit 138n/a
Operating Income 35n/a
EBITDA 54n/a
Net Profit 16n/a
Balance Sheet
Cash and Cash Equivalents 62n/a
Receivables 261n/a
Total Current Assets 481n/a
PP&E 10n/a
Total Assets 1,059n/a
Accounts Payable 111n/a
Current Debt 14n/a
Total Current Liabilities 232n/a
Long-Term Debt 353n/a
Total Liabilities 656n/a
Total Equity 402n/a
Cash Flow
Depreciation & Amortisation 19n/a
Change in Working Capital -3n/a
Operating Cash Flow 46n/a
Net Change in PP&E and Intangibles -5n/a
Investing Cash Flow -275n/a
Dividends Paid -8n/a
Financing Cash Flow 236n/a
Total Change in Cash 7n/a
Free Cash Flow 38n/a
Profitability Ratios
Gross Margin 23.8%n/a
Operating Margin 6.1%n/a
Net Profit Margin 2.8%n/a
Return on Equity 4.0%n/a
Return on Assets 1.5%n/a
Per Share Figures
Basic EPS 0.52n/a
Diluted EPS 0.52n/a
Sales per Share 18.75n/a
Book Value per Share 13.02n/a
FCF per Share 1.22n/a
Dividends per Share 0.25n/a
Price Multiples
Price to Earnings Ratio 21.30n/a
Price to Sales Ratio 0.60n/a
Price to Book Value 0.86n/a
Price to Free Cash Flow 9.17n/a
Valuation Metrics
EV/EBITDA 11.93n/a
EV/Sales 1.11n/a
Book to Market Value 1.20n/a
Other Ratios
Current Ratio 207.2%n/a
Liabilities to Equity Ratio 163.2%n/a
Debt to Assets Ratio 34.7%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
347
412
444
500
510
547
559
Sales & Services Revenue
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
Cost of revenue
-292
-347
-362
-401
-395
-412
-416
Cost of Goods & Services
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
Gross Profit
54
66
82
98
115
135
143
Other Operating Income
0
0
0
0
0
0
0
Operating Expenses
-45
-49
-57
-64
-70
-79
-85
Selling, General & Administrative
-45
-49
-55
-61
-65
-73
-77
Selling & Marketing
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
Research & Development
0
0
-2
-3
-5
-6
-8
Depreciation & Amortization
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
Operating Income (Loss)
9
17
25
34
44
56
58
Non-Operating Income (Loss)
1
0
-1
0
0
-2
-4
Interest Expense, net
1
0
-1
0
0
-2
-4
Interest Expense
0
-2
-3
-2
-2
-4
-7
Interest Income
1
2
2
2
3
1
3
Other Investment Income (Loss)
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
0
0
Pretax Income (Loss), Adjusted
10
17
25
35
45
54
54
Abnormal Gains (Losses)
0
0
0
0
0
0
0
Acquired In-Process R&D
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
Pretax Income (Loss)
10
17
25
35
45
54
54
Income Tax (Expense) Benefit, net
-4
-8
-8
-12
-16
-20
-19
Current Income Tax
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
7
9
17
22
29
33
35
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
7
9
17
22
29
33
35
Minority Interest
0
0
0
0
0
0
0
Net Income
7
9
17
22
29
33
35
Preferred Dividends
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
7
9
17
22
29
33
35
Remarks
restated on Sep 7, 2012 n/a
calculated values,
restated on Aug 29, 2013 n/a
calculated values,
restated on Sep 5, 2014 n/a
calculated values,
restated on Sep 11, 2015 n/a
calculated values,
restated on Aug 26, 2016 n/a
calculated values,
restated on Aug 26, 2016 n/a
calculated values,
restated on Aug 26, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
30
26
35
44
37
68
Cash & Cash Equivalents
n/a
29
25
33
43
34
67
Short Term Investments
n/a
1
2
2
1
3
1
Accounts & Notes Receivable
n/a
84
75
90
123
162
168
Accounts Receivable, Net
n/a
84
75
90
123
162
168
Notes Receivable, Net
n/a
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
Inventories
n/a
77
85
84
101
96
98
Raw Materials
n/a
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
Other Short Term Assets
n/a
8
6
9
9
16
19
Prepaid Expenses
n/a
2
2
3
4
3
3
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
1
1
1
0
2
3
Income Taxes Receivable
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
5
3
5
5
11
13
Total Current Assets
n/a
199
192
218
276
310
353
Property, Plant & Equipment, Net
n/a
12
12
11
12
10
10
Property, Plant & Equipment
n/a
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
Other Long Term Assets
n/a
101
96
94
180
169
178
Intangible Assets
n/a
51
45
41
88
79
79
Goodwill
n/a
34
33
34
67
68
68
Other Intangible Assets
n/a
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
3
5
8
12
10
18
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
4
4
4
6
7
7
Investments in Affiliates
n/a
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
9
8
7
8
6
6
Total Noncurrent Assets
n/a
113
107
105
192
179
188
Total Assets
n/a
312
299
323
468
490
541
Liabilities and owners' equity
Payables & Accruals
n/a
77 76633000
67 66928000
78 78193000
110 110180000
115 114803000
99 98709000
Accounts Payable
n/a
45 44614000
42 42007000
39 39222000
49 48716000
55 54962000
46 46034000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
32 32019000
25 24921000
39 38971000
61 61464000
60 59841000
53 52675000
Short Term Debt
n/a
6 6247000
7 6713000
12 11714000
8 8343000
10 10197000
0 197000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
6 6247000
7 6713000
12 11714000
8 8343000
10 10197000
0 197000
Other Short Term Liabilities
n/a
0 306000
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 306000
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Total Current Liabilities
n/a
83 83186000
74 73641000
90 89907000
119 118523000
125 125000000
99 98906000
Long Term Debt
n/a
49 48750000
39 39052000
20 20355000
97 97158000
100 99960000
119 118592000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
19 18908000
19 18584000
19 18528000
19 18719000
11 10603000
19 18838000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 51000
0 8000
0 6000
0 6000
0 66000
9 9142000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
19 18857000
19 18576000
19 18522000
19 18713000
11 10537000
10 9696000
Total Noncurrent Liabilities
n/a
68 67658000
58 57636000
39 38883000
116 115877000
111 110563000
137 137430000
Total Liabilities
n/a
151 150844000
131 131277000
129 128790000
234 234400000
236 235563000
236 236336000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
63 62595000
64 64340000
73 73123000
87 87444000
94 94099000
116 115963000
Common Stock
n/a
0 266000
0 269000
0 278000
0 288000
0 292000
0 296000
Additional Paid in Capital
n/a
62 62329000
64 64071000
73 72845000
87 87156000
94 93807000
116 115667000
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 -230000
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
91 90713000
102 102344000
119 118615000
141 140768000
167 167208000
195 194804000
Other Equity
n/a
8 7743000
1 1319000
3 2902000
5 5372000
-7 -7096000
-6 -6325000
Equity Before Minority Interest
n/a
161 160821000
168 168003000
195 194640000
234 233584000
254 254211000
304 304442000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
161 160821000
168 168003000
195 194640000
234 233584000
254 254211000
304 304442000
Total Liabilities & Equity
n/a
312 311665000
299 299280000
323 323430000
468 467984000
490 489774000
541 540778000
Remarks restated on n/a restated on Sep 7, 2012 n/a restated on Aug 29, 2013 n/a restated on Sep 5, 2014 n/a restated on Sep 11, 2015 n/a restated on Aug 26, 2016 n/a restated on May 5, 2017 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
7
9
17
22
29
33
35
Net Income
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Depreciation & Amortization
3
6
7
7
8
12
13
Non-Cash Items
0
-1
-1
1
-2
0
8
Stock-Based Compensation
1
1
1
2
3
5
7
Deferred Income Taxes
-1
-1
-2
-3
-3
-2
0
Other Non-Cash Adjustments
0
-2
-1
2
-2
-3
2
Change in Working Capital
-24
3
-8
-5
-10
-37
-24
(Increase) Decrease in Accounts Receivable
-31
2
6
-15
-19
-44
-6
(Increase) Decrease in Inventories
-23
2
-10
2
-8
0
-2
Increase (Decrease) in Accounts Payable
16
2
-1
-3
5
8
-9
Increase (Decrease) in Other
14
-4
-3
12
12
0
-7
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
Cash from Operating Activities
-14
16
15
25
25
8
32
Change in Fixed Assets & Intangibles
-8
-7
-1
-3
-2
-2
-12
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
-8
-7
-2
-3
-2
-2
-12
Purchase of Fixed Assets
-4
-5
-1
-1
-1
-1
-1
Acquisition of Intangible Assets
-4
-2
-1
-2
-1
-2
-11
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
-1
-1
1
-3
2
Decrease in Long Term Investment
0
0
0
2
2
0
3
Increase in Long Term Investment
0
0
-1
-3
0
-3
0
Net Cash From Acquisitions & Divestitures
0
-64
0
0
-86
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
-64
0
0
-86
0
0
Other Investing Activities
1
1
0
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
Cash from Investing Activities
-7
-71
-2
-3
-87
-5
-10
Dividends Paid
-5
-5
-5
-6
-7
-7
-7
Cash From (Repayment of) Debt
1
51
-9
-14
73
5
37
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
1
51
-9
-14
73
5
37
Repayments of Long Term Debt
0
-15
-9
-24
-41
-14
-123
Cash From Long Term Debt
1
65
0
10
114
19
159
Cash From (Repurchase of) Equity
2
1
1
6
4
1
1
Increase in Capital Stock
2
1
1
6
4
1
1
Decrease in Capital Stock
0
0
0
0
0
0
0
Other Financing Activities
0
4
-1
-1
0
-7
-19
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
Cash from Financing Activities
-2
50
-15
-14
71
-8
11
Net Cash Before Disc. Operations and FX
-24
-5
-2
8
9
-5
33
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
Net Cash Before FX
-24
-5
-2
8
9
-5
33
Effect of Foreign Exchange Rates
-3
3
-2
0
1
-4
0
Net Changes in Cash
-27
-2
-4
8
10
-9
33
Remarks
restated on Sep 7, 2012 n/a
calculated values,
restated on Aug 29, 2013 n/a
calculated values,
restated on Sep 5, 2014 n/a
calculated values,
restated on Sep 11, 2015 n/a
calculated values,
restated on Aug 26, 2016 n/a
calculated values,
restated on Aug 26, 2016 n/a
calculated values,
restated on Aug 26, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo